SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Net Current Assets History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹51 Cr | ₹41 Cr | ₹30 Cr | ₹28 Cr | ₹25 Cr |
What is the latest Net Current Assets ratio of SHREE GANESH REMEDIES ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹51 Cr |
Mar2023 | ₹41 Cr |
Mar2022 | ₹30 Cr |
Mar2021 | ₹28 Cr |
Mar2020 | ₹25 Cr |
How is Net Current Assets of SHREE GANESH REMEDIES Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹51 Cr | 25.23 | |
Mar2023 | ₹41 Cr | 37.55 | |
Mar2022 | ₹30 Cr | 7.42 | |
Mar2021 | ₹28 Cr | 10.56 | |
Mar2020 | ₹25 Cr | - |
Compare Net Current Assets of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹1,081.2 Cr | 27.6% | 24.6% | 6.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,228.0 Cr | -2.4% | -7.2% | 27.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹148,023.0 Cr | 0% | -9.2% | 61.5% | Stock Analytics | |
CIPLA | ₹119,474.0 Cr | 6% | -3.8% | 10.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,599.0 Cr | 1.7% | -11.4% | 2.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,604.7 Cr | 5.2% | -2.1% | 26.1% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | 27.6% |
24.6% |
6.7% |
SENSEX | 1.7% |
-1.3% |
7.7% |
You may also like the below Video Courses